Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 70 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BIO.F
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Biotest Aktiengesellschaft stock price down 0% on Wednesday
(Updated on May 15, 2024)

Sell candidate since May 10, 2024 PDF

No changes to the price of Biotest Aktiengesellschaft stock on the last trading day (Wednesday, 15th May 2024). During the last trading day the stock fluctuated 0% from a day low at 41.60€ to a day high of 41.60€. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock is moving within a narrow and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Biotest Aktiengesellschaft stock with a 90% probability to be traded between 40.68€ and 41.84€ at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BIO.F Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biotest Aktiengesellschaft stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 41.63€ and 41.83€. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 03, 2024, and so far it has fallen -1.42%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Biotest Aktiengesellschaft stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved 0€ between high and low, or 0%. For the last week the stock has had daily average volatility of 0.487%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIO.F) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Biotest Aktiengesellschaft to open at 41.60€, and during the day (based on 14 day Average True Range), to move between 41.40€ and 41.80€, which gives a possible trading interval of +/-0.198€ (+/-0.48%) up or down from last closing price. If Biotest Aktiengesellschaft takes out the full calculated possible swing range there will be an estimated 0.95% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ 42.00€, some 0.400€ (0.96%) from the current price of 41.60€, our system finds the risk reward not very attractive.

Is Biotest Aktiengesellschaft stock A Buy?

Biotest Aktiengesellschaft holds several negative signals and is within a narrow and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.896 Sell Candidate Unchanged

Predicted Opening Price for Biotest Aktiengesellschaft of Thursday, May 16, 2024

Fair opening price May 16, 2024 Current price
41.60€ ( 0%) 41.60€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BIO.F

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 41.60 .
R2 41.60 .
R1 41.60 .
Current price: 41.60
Support S1 41.60 .
S2 41.60 .
S3 41.60 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 42.60 2.40 %
R2 42.20 1.44 %
R1 42.00 0.96 %
Current price 41.60
Support S1 0 .
S2 0 .
S3 0 .

BIO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 08, 2024 May 08, 2024 May 10, 2024 0.0400€ 0%
2 May 08, 2019 May 08, 2019 May 08, 2019 0.0400€ 0%
3 May 16, 2018 May 16, 2018 May 16, 2018 0.0400€ 0%
4 Mar 29, 2017 Aug 31, 2017 Sep 04, 2017 0.0500€ 0%
5 Mar 23, 2016 May 13, 2016 May 13, 2016 0.0200€ 0%

FAQ

What is the symbol for Biotest Aktiengesellschaft Stock and on which exchange is it traded?
The symbol for Biotest Aktiengesellschaft is BIO.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Biotest Aktiengesellschaft Stock?
Biotest Aktiengesellschaft holds several negative signals and is within a narrow and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Biotest Aktiengesellschaft Stock?
Biotest Aktiengesellschaft Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biotest Aktiengesellschaft Stock.

What's the current price of Biotest Aktiengesellschaft Stock?
As of the end of day on the May 15, 2024, the price of an Biotest Aktiengesellschaft (BIO.F) share was 41.60€.

What is the 52-week high and low for Biotest Aktiengesellschaft Stock?
The 52-week high for Biotest Aktiengesellschaft Stock is 44.00€ and the 52-week low is 40.40€.

What is the market capitalization of Biotest Aktiengesellschaft Stock?
As of the May 15, 2024, the market capitalization of Biotest Aktiengesellschaft is 1.38B.

When is the next earnings date for Biotest Aktiengesellschaft?
The upcoming earnings date for Biotest Aktiengesellschaft is Jul 30, 2024.
Click to get the best stock tips daily for free!

About Biotest Aktiengesellschaft

Biotest Aktiengesellschaft Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophyl... BIO.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT